Samples for study ST000514
Species: Mus musculus (Factor headings shown in green)
| mb_sample_id | Subject name | Sample name | Group | Sample_Data:assay |
|---|---|---|---|---|
| SA026728 | 1849 | ms5629-19 | Control colch | Genotype:Irlox IGFRlox | Treatment:Colch | Concentration of AA + metabolites in serum |
| SA026727 | 606 | ms5629-20 | Control colch | Genotype:Irlox IGFRlox | Treatment:Colch | Concentration of AA + metabolites in serum |
| SA026725 | 1826 | ms5629-21 | Control colch | Genotype:Irlox IGFRlox | Treatment:Colch | Concentration of AA + metabolites in serum |
| SA026726 | 1847 | ms5629-22 | Control colch | Genotype:Irlox IGFRlox | Treatment:Colch | Concentration of AA + metabolites in serum |
| SA026730 | 1944 | ms5629-24 | Control colch | Genotype:Irlox | Treatment:Colch | Concentration of AA + metabolites in serum |
| SA026729 | 1958 | ms5629-25 | Control colch | Genotype:Irlox | Treatment:Colch | Concentration of AA + metabolites in serum |
| SA026724 | 1818 | ms5629-23 | Control colch | Genotype:- | Treatment:Colch | Concentration of AA + metabolites in serum |
| SA026753 | 1989 | ms5629-7 | control | Genotype:IR -/- IGFR -/- | Treatment:saline | Concentration of AA + metabolites in serum |
| SA026755 | 613 | ms5629-1 | control | Genotype:Irlox IGFRlox | Treatment:saline | Concentration of AA + metabolites in serum |
| SA026754 | 595 | ms5629-2 | control | Genotype:Irlox IGFRlox | Treatment:saline | Concentration of AA + metabolites in serum |
| SA026756 | 1837 | ms5629-3 | control | Genotype:Irlox IGFRlox | Treatment:saline | Concentration of AA + metabolites in serum |
| SA026757 | 2005 | ms5629-4 | control | Genotype:Irlox | Treatment:saline | Concentration of AA + metabolites in serum |
| SA026759 | 1942 | ms5629-5 | control | Genotype:Irlox | Treatment:saline | Concentration of AA + metabolites in serum |
| SA026758 | 1956 | ms5629-6 | control | Genotype:Irlox | Treatment:saline | Concentration of AA + metabolites in serum |
| SA026731 | 1965 | ms5629-34 | HFD + Colch | Genotype:Irlox IGFRlox | Treatment:Colch | Concentration of AA + metabolites in serum |
| SA026734 | 1951 | ms5629-32 | HFD + Colch | Genotype:Irlox | Treatment:Colch | Concentration of AA + metabolites in serum |
| SA026733 | 1952 | ms5629-33 | HFD + Colch | Genotype:Irlox | Treatment:Colch | Concentration of AA + metabolites in serum |
| SA026735 | 1991 | ms5629-35 | HFD + Colch | Genotype:Irlox | Treatment:Colch | Concentration of AA + metabolites in serum |
| SA026732 | 1994 | ms5629-36 | HFD + Colch | Genotype:Irlox | Treatment:Colch | Concentration of AA + metabolites in serum |
| SA026736 | 1964 | ms5629-17 | HFD | Genotype:Irlox IGFRlox | Treatment:saline | Concentration of AA + metabolites in serum |
| SA026738 | 1947 | ms5629-14 | HFD | Genotype:Irlox | Treatment:saline | Concentration of AA + metabolites in serum |
| SA026740 | 1950 | ms5629-15 | HFD | Genotype:Irlox | Treatment:saline | Concentration of AA + metabolites in serum |
| SA026739 | 1960 | ms5629-16 | HFD | Genotype:Irlox | Treatment:saline | Concentration of AA + metabolites in serum |
| SA026737 | 1988 | ms5629-18 | HFD | Genotype:Irlox | Treatment:saline | Concentration of AA + metabolites in serum |
| SA026745 | 1852 | ms5629-26 | MIGIRKO colch | Genotype:IR -/- IGFR -/- | Treatment:Colch | Concentration of AA + metabolites in serum |
| SA026742 | 1853 | ms5629-27 | MIGIRKO colch | Genotype:IR -/- IGFR -/- | Treatment:Colch | Concentration of AA + metabolites in serum |
| SA026746 | 1856 | ms5629-28 | MIGIRKO colch | Genotype:IR -/- IGFR -/- | Treatment:Colch | Concentration of AA + metabolites in serum |
| SA026743 | 1817 | ms5629-29 | MIGIRKO colch | Genotype:IR -/- IGFR -/- | Treatment:Colch | Concentration of AA + metabolites in serum |
| SA026744 | 607 | ms5629-30 | MIGIRKO colch | Genotype:IR -/- IGFR -/- | Treatment:Colch | Concentration of AA + metabolites in serum |
| SA026741 | 1824 | ms5629-31 | MIGIRKO colch | Genotype:IR -/- IGFR -/- | Treatment:Colch | Concentration of AA + metabolites in serum |
| SA026749 | 1838 | ms5629-10 | MIGIRKO | Genotype:IR -/- IGFR -/- | Treatment:saline | Concentration of AA + metabolites in serum |
| SA026747 | 1815 | ms5629-11 | MIGIRKO | Genotype:IR -/- IGFR -/- | Treatment:saline | Concentration of AA + metabolites in serum |
| SA026750 | 2028 | ms5629-12 | MIGIRKO | Genotype:IR -/- IGFR -/- | Treatment:saline | Concentration of AA + metabolites in serum |
| SA026748 | 2029 | ms5629-13 | MIGIRKO | Genotype:IR -/- IGFR -/- | Treatment:saline | Concentration of AA + metabolites in serum |
| SA026752 | 615 | ms5629-8 | MIGIRKO | Genotype:IR -/- IGFR -/- | Treatment:saline | Concentration of AA + metabolites in serum |
| SA026751 | 597 | ms5629-9 | MIGIRKO | Genotype:IR -/- IGFR -/- | Treatment:saline | Concentration of AA + metabolites in serum |
